Poultry workers in the
The use of antimicrobials in industrial food production has been going on for over 50 years in the United States, said the studys lead author, Lance B. Price, PhD, who serves on the research faculty at the Johns Hopkins School of Medicine, Division of Infectious Disease, and is a scientific advisor to the Johns Hopkins Center for a Livable Future. Some estimates indicate that well over half of the antimicrobial drugs produced in the United States are used in food animal production. In the U.S. alone, over 9 billion food animals are produced annually.
The study was conducted with poultry workers and community residents in the eastern shore regions of Maryland and Virginia, and it confirms similar studies in Europe showing that poultry farmers and workers are at risk of exposure to drug-resistant E. coli bacteria. The Maryland and Virginia regions on the Delmarva Peninsula are among the top broiler chicken producing regions in the U.S., producing more than 600 million chickens annually.
In the study, researchers conducted in-depth analyses of 49 study participants, 16 working within the poultry industry and 33 community residents. Stool samples from the participants were tested for resistance to the antimicrobials ampicillin, ciprofloxacin, ceftriazone, gentamicin and tetracycline. Findings showed that poultry workers had 32 times greater odds of being colonized with gentamicin-resistant E. coli than other members of the community.
One of the major implications of this study is to underscore the importance of the non-hospital environment in the origin of drug resistant infections, said Ellen K. Silbergeld, PhD, senior author of the study.
Price and other researchers note that as food animal production shifted from the independent farmer to large-scale, industrialized operations, the use of antimicrobials in feeds intended to stimulate growth has increased. Currently 16 different antimicrobial drugs are approved for use in U.S. poultry production with gentamicin reported to be the most widely used.
Additional study authors are Jay P. Graham, Lelia G. Lackey, Amira Roess and Rocio Vailes, all at the Johns Hopkins Bloomberg School of Public Health.
The majority of this research was supported with grants from the Johns Hopkins Center for a Livable Future.
Source: Johns Hopkins Center for a Livable Future